Skip to main content
Jafron Biomedical Co.,Ltd. logo

Jafron Biomedical Co.,Ltd. — Investor Relations & Filings

Ticker · 300529 ISIN · CNE100002995 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,842 across all filing types
Latest filing 2019-03-22 Director's Dealing
Country CN China
Listing Shenzhen Stock Exchange 300529

About Jafron Biomedical Co.,Ltd.

https://www.jafron.com

Jafron Biomedical Co.,Ltd. specializes in the research, development, and manufacturing of biomaterials and equipment for blood purification. The company is a primary provider of hemoperfusion technology, focusing on the production of adsorbent cartridges designed to remove specific toxins and inflammatory mediators from the bloodstream. Its core product portfolio includes the HA series of hemoperfusion cartridges, which are applied in clinical settings for end-stage renal disease, acute poisoning, critical care, and liver failure. Beyond consumables, the company develops blood purification machines and integrated treatment systems. These solutions target clinical applications in nephrology, intensive care, and hepatology. By leveraging advanced resin adsorption technology, the company provides specialized extracorporeal blood treatment options aimed at improving patient outcomes in complex medical conditions.

Recent filings

Filing Released Lang Actions
关于控股股东、实际控制人减持股份的预披露公告
Director's Dealing Classification · 100% confidence The document is a public announcement regarding the planned reduction of shares held by the controlling shareholder and actual controller of the company. It details the shareholder's identity, shareholding percentage, reasons for share reduction, methods, timing, and legal compliance. There is no financial data, earnings information, or report attached or referenced as being published. The document is a notification about a director's personal share transactions (share reduction by a major shareholder who is also a director). This fits the definition of Director's Dealing (DIRS). The document length is short and focused solely on shareholding changes by a director, confirming the classification.
2019-03-22 Chinese
关于向银行申请综合授信额度的公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement (489 characters) regarding the company's board approval to apply for a comprehensive credit facility from banks. It mentions the board meeting date and the credit amount but contains no financial statements or detailed financial data. It is an update on financing activities, specifically about credit/loan facilities. The document is not a full financial report, audit, or earnings release. It fits the definition of a Capital/Financing Update (CAP).
2019-02-26 Chinese
关于孙公司与众惠财产相互保险社签订保险经纪业务合作协议的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a cooperation agreement between the company's subsidiary and an insurance mutual society. It details the signing of an insurance brokerage business cooperation agreement, the parties involved, the terms, and the expected impact on the company. It includes board approval and independent director opinions. The document is relatively short (3030 characters) and does not contain financial statements or detailed financial data. It is not a full report but an announcement of a business cooperation agreement. There is no indication of a report being attached or published. Therefore, this document fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement about a business cooperation agreement that does not fit other specific categories like MANG (management changes) or CAP (capital updates).
2019-02-26 Chinese
独立董事关于第三届董事会第三十一次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors regarding a specific board meeting (the 31st meeting of the 3rd board). It discusses the review and approval of a business cooperation agreement and confirms compliance with relevant regulations and company bylaws. There is no financial data, no mention of annual or quarterly reports, earnings, or other financial disclosures. The document is related to board/management information, specifically an announcement or opinion from board members about a corporate matter. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on governance and board opinions, not a full report or announcement of voting results.
2019-02-26 Chinese
第三届董事会第三十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a specific board meeting of 健帆生物科技集团股份有限公司 (Jianfan Bio-Technology Group Co., Ltd.). It details the date and attendance of the board meeting, the voting results on specific proposals, and references to further detailed announcements on a regulatory disclosure website. There is no financial data, no detailed management discussion, no audit or annual report content, and no mention of shareholder voting results beyond the board itself. The document is clearly about board meeting decisions and changes, fitting the category of Board/Management Information (MANG). The document length is short and it is not a report or presentation but a formal announcement of board resolutions.
2019-02-26 Chinese
关于部分董事减持计划实施完毕的公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding the completion of a shareholding reduction plan by certain directors and executives of the company. It details the number of shares reduced, the methods of reduction, dates, and compliance with relevant securities laws and regulations. There is no financial report, earnings data, or management discussion of financial results. The document focuses on insider share transactions by company directors and executives. Therefore, it fits the category of Director's Dealing (DIRS). The document length is short and it is not a report publication or certification, so it is not RPA or RNS.
2019-02-22 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.